Dna (recombinant Adeno-associated Virus 6 Vector Pf-07055480 Human B-domain-deleted Blood-coagulation Factor Viii-specifying)
Dna (recombinant Adeno-associated Virus 6 Vector Pf-07055480 Human B-domain-deleted Blood-coagulation Factor Viii-specifying) Uses, Dosage, Side Effects, Food Interaction and all others data.
Dna (recombinant Adeno-associated Virus 6 Vector Pf-07055480 Human B-domain-deleted Blood-coagulation Factor Viii-specifying) is under investigation in clinical trial NCT04370054 (Study to Evaluate the Efficacy and Safety of PF-07055480 in Moderately Severe to Severe Hemophilia a Adults).
| Trade Name | Dna (recombinant Adeno-associated Virus 6 Vector Pf-07055480 Human B-domain-deleted Blood-coagulation Factor Viii-specifying) |
| Generic | Giroctocogene fitelparvovec |
| Giroctocogene fitelparvovec Other Names | Aav2/6-b-domain-deleted blood coagulation factor viii, Dna (recombinant adeno-associated virus 6 vector pf-07055480 human b-domain-deleted blood-coagulation factor viii-specifying), Giroctocogene fitelparvovec |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Dna (recombinant Adeno-associated Virus 6 Vector Pf-07055480 Human B-domain-deleted Blood-coagulation Factor Viii-specifying)
